SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Celgene-CELG
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
804 71 0 CELG
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
404 I hesitate to disturb this quiet thread, but I think your stock is going to cloCheryl Galt-2/9/2000
403 Shity CC, good prospectus. [eom]Miljenko Zuanic-1/27/2000
402 New PDE-4 classes inhibitors {2-[1-(3-ethoxy-4-methoxyphenyl)-2-(N,N-dimethylamMiljenko Zuanic-1/26/2000
401 V1, <<You would be surprised how many buysiders do not have the IMS dataMiljenko Zuanic-1/26/2000
400 Miljenko, Wow is right on a day when the NASDAQ is down 97. Street expectationVector1-1/26/2000
399 13 points up! WOW! Why did I sold part of my CELG holding south of 70, 60 and Miljenko Zuanic-1/26/2000
398 Cheryl, The market is looking for a blowout quarter. I hope the company meets eVector1-1/26/2000
397 4Q Report and conference call coming tomorrow, 9AM biz.yahoo.com Celgene CorpoCheryl Galt-1/26/2000
396 Celgene Files Registration Statement for Public Offering WARREN, N.J., Jan. 19Cheryl Galt-1/19/2000
395 Looks like biotech will be the place to be in 2000, and CELG is where I'm pswisstrader-12/24/1999
394 <Study Backs a Drug for Hyperactive Children > Hopefully this is just ovLLCF-12/19/1999
393 Study Backs a Drug for Hyperactive Children ---------------------------------Vector1-12/16/1999
392 This was also covered in the NY Times a few days ago. CELG may still be a bargaVector1-12/15/1999
391 Strong study backs Ritalin: archpsyc.ama-assn.org Note best results were achiBiomaven-12/15/1999
390 Peter, 20 pts was enrolled. I think all completed study, so do not know why CEMiljenko Zuanic-11/29/1999
389 Crohn's pilot study - this may turn out to be another viable market: <iBiomaven-11/29/1999
388 Another very positive write-up from Raging Bull. ragingbull.comsmh-11/25/1999
387 Reuters summary of NEJM article: pharmacotherapy.medscape.comj_fir2-11/24/1999
386 Peter, on front page of at least the early edition of today's NYTimes. HopeWTDEC-11/18/1999
385 This is what I like, that low doses (100-200 mg) is as effective as high dosesMiljenko Zuanic-11/17/1999
384 Peter, Max, Thanks. The most interesting thing from NEJM editorial: <<TMiljenko Zuanic-11/17/1999
383 And here's another mention from AP: <i>News Alert from AP Online viaBiomaven-11/17/1999
382 Thanks, PB. I forgot that NEJM mails before the issue date, and also before it Biomaven-11/17/1999
381 Well, the issue was mailed already it seems. This was posted yesterday: raginPseudo Biologist-11/17/1999
380 And here's the reason for the nice run. NEJM will be upset, as they don'Biomaven-11/17/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News